Brawn Biotech Share Price | Brawn Biotech Stock Screener
BRAWN
Pharmaceuticals
Share Price BSE
₹19.75
▲
0.05 (0.25%)
As of July 3, 2026, the Brawn Biotech share price (BSE: BRAWN) is ₹19.75, up 0.25% from the previous close, with shares trading between ₹18.80 and ₹19.75, and a 52-week range of ₹16.66–₹24.35.
Analyse BRAWN share price data and track historical price performance.
Use the Brawn Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Brawn Biotech Market Cap
₹6.80 Cr.
BRAWN P/E Ratio (TTM)
31.40
Brawn Biotech P/B Ratio
2.27
EPS (TTM)
₹3.26
Dividend Yield
-
Debt to Equity
-
BRAWN 52 Week High
₹24.35
Brawn Biotech 52 Week Low
₹16.66
Operating Margin
-33.00%
Profit Margin
-
BRAWN Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹21.00
Total Equity
₹4.00
Brawn Biotech Share Price Chart
Screen Brawn Biotech share price with an interactive chart. Analyse BRAWN price trends and volatility across different timeframes.
Brawn Biotech Company Profile - Fundamental Screener
Screen Brawn Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BRAWN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE899B01015
Brawn Biotech Balance Sheet Screener
Screen BRAWN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 21 | 21 | 15 | 15 | 14 | 14 | 20 | 23 | 23 | 17 |
| Current Assets | 17 | 18 | 13 | 13 | 12 | 13 | 19 | 22 | 22 | 17 |
| Fixed Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 8 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4 | 3 | 5 | 6 | 7 | 9 | 9 | 9 | 8 | 7 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 1 | 0 | 2 | 3 | 4 | 6 | 6 | 6 | 5 | 4 |
Brawn Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Brawn Biotech income statement and profit fundamentals.
Analyze BRAWN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Brawn Biotech share price evaluation.
| Item | 2023-Jun | 2023-Mar | 2022-Jun |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 |
| Operating Profit % | -33.00% | 25.00% | 25.00% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 |
| EPS | -0.08 | 0.47 | 0.05 |
Brawn Biotech Cash Flow Screener - Liquidity Fundamentals
Screen BRAWN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 2 | 0 |
Brawn Biotech Shareholding Pattern Screener
See Brawn Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Brawn Biotech promoter holding and ownership changes for BRAWN on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.94% | 53.66% | 53.66% | 53.66% | 53.39% | 53.64% | 53.64% | 53.64% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.49% | 33.17% | 32.88% | 32.90% | 30.97% | 33.91% | 33.96% | 33.84% |
| Other Holding | 16.22% | 12.82% | 13.11% | 13.09% | 15.29% | 12.10% | 12.05% | 12.17% |
| Shareholder Count | 3,303 | 4,024 | 3,975 | 3,958 | 3,444 | 4,160 | 4,090 | 4,157 |
Brawn Biotech Share Dividend Screener - Share Yield Analysis
Check Brawn Biotech dividend history with payout and yield data.
View Brawn Biotech dividend details including ex-dates and amounts for BRAWN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹1.00 | 2.69% |
| 2017-March | ₹1.50 | 2.79% |
Brawn Biotech Stock Index Membership
See which indices include Brawn Biotech stock.
Check BRAWN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Brawn Biotech Market Events Screener - Corporate Actions
Get Brawn Biotech corporate actions including splits, bonuses, and buybacks.
Check Brawn Biotech stock events that may affect BRAWN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -13.35% | ||
| Annual General Meeting | NA | 0.10% | ||
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -6.81% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -3.48% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 9.95% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -16.28% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 1.04% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 25.30% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.44% |
Brawn Biotech Competitors Screener - Peer Comparison
Screen BRAWN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,019 | 38.82 | 58,220 | 6.38% | 11,565 | 62.37 |
| Divis Laboratories | 174,944 | 69.38 | 10,560 | 8.73% | 2,520 | 52.31 |
| Torrent Pharmaceuticals | 156,646 | 71.51 | 13,886 | 20.34% | 2,138 | 56.90 |
| Cipla | 118,647 | 30.13 | 29,045 | 2.24% | 3,870 | 65.46 |
| Dr Reddys Laboratories | 115,581 | 27.10 | 33,593 | -0.44% | 3,998 | 69.37 |
| Zydus Life Science | 112,004 | 21.63 | 26,720 | 13.65% | 5,242 | 61.62 |
| Lupin | 108,772 | 20.00 | 27,488 | 19.98% | 5,345 | 58.20 |
| Mankind Pharma | 103,065 | 52.44 | 14,278 | 12.03% | 1,750 | 57.08 |
| Aurobindo Pharma | 90,379 | 25.78 | 33,385 | 3.21% | 3,376 | 67.06 |
| Laurus Labs | 79,904 | 88.02 | 6,868 | 22.01% | 890 | 64.65 |
Brawn Biotech Company Announcements - News Screener
Screen BRAWN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Closure of Trading Window | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Intimation Regarding Non-Applicability Of Regulation 23(9) | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Results- Financial Results For Year Ended 31St March 2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 29Th May 2026 And Submissions Of Audited Financial Results For The Quarter And Year Ended 31.03.2026 | - |
| 2026-05-21 | Board Meeting Intimation for Board Meeting To Consider And Approve Inter Alia The Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026. | - |
| 2026-04-13 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-25 | Board Meeting Outcome for ANNOUNCEMENT UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) 2015 | - |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON TODAY | - |
| 2026-02-14 | Results - Financial Results For 31/12/2025 | - |
| 2026-02-06 | Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1) | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2025-12-29 | Announcement Under Regulation 30 (LODR) | - |